UncategorizedReParris emerges to redefine aging as a ‘treatable condition’ Empower Meds / November 24, 2025
UncategorizedJunction lands $18m for tech to enable decentralized healthcare Empower Meds / November 24, 2025
UncategorizedExposome has tenfold impact on mortality risk compared with genetics Empower Meds / November 24, 2025
UncategorizedElysium Health launches cofactor, 4-in-1 collagen with NAD+ boost – Longevity.Technology Empower Meds / November 24, 2025
UncategorizedNext Health selects Houston for major expansion – Longevity.Technology Empower Meds / November 23, 2025
UncategorizedInsilico seals unicorn status after landing $110m for AI drug discovery Empower Meds / November 23, 2025
UncategorizedLife Bio ready for world’s first partial epigenetic reprogramming trials Empower Meds / November 23, 2025
UncategorizedFounders Longevity Forum London reveals first wave of speakers Empower Meds / November 23, 2025
